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Abstract. Parkinson’s disease is the second most common neurodegenerative
disorder, in which both alpha-synuclein (α-syn) and dopamine (DA) have a critical
role. α-Syn is known to be natively unstructured in equilibrium with subpopulations
of more compact structures. It is these compact structures that are thought to be
linked to amyloid formation. In the presence of DA, α-syn yields a diverse range of
SDS-resistant, non-amyloid oligomers, however the precursor state conformation
has not been established. Here, three DA molecules have been observed to bind
per α-syn monomer by electrospray-ionization-ion mobility spectrometry-mass
spectrometry (ESI-IMS-MS). Each of these DA molecules binds exclusively to the
extended conformation of α-syn, and binding is not observed in the compact state
of the protein. Measurements of collisional cross sectional areas show that the incremental uptake of DA
pushes the protein towards a highly extended population, becoming fully populated upon the binding of three
DA ligands. Tyrosine (Tyr) as a closely related structural analog, exhibited limited binding to the protein as
compared with DA, with a maximum of two ligands being observed. Those Tyr ligands that do bind were
observed as adducts to the extended conformation akin to DA. These findings suggest DA is able to
modulate α-syn self-assembly by inducing the population of a highly extended state.
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Introduction
Alpha-synuclein (α-syn) is an intrinsically disorderedprotein that is closely associated with Parkinson’s
disease (PD) and other neurodegenerative disease states
[1]. The selective loss of dopaminergic neurons and the
deposition of Lewy bodies (LBs) mainly comprised of
fibrillar α-syn in the substantia nigra pars compacta are
characteristic hallmarks of PD [1]. Oxidative stress has
been shown to be one of the key mechanisms involved
in neurotoxicity, giving a possible explanation as to why
dopaminergic neurons are highly vulnerable to cell death:
in the cytoplasm, dopamine (DA) can undergo oxidation
because of its labile quinone ring in the presence of
molecular oxygen producing reactive oxidative species
(ROS) and dopamine quinones. ROS then can account
for the damage in the cellular components, for example
in the mitochondria through association of α-syn with
oxidized lipids [2]. Since α-syn is thought to play an
essential role in the modulation of synaptic vesicle
recycling, DA storage and release at the nerve terminals
[3], mutations in the protein in the familiar forms of the
disease or changes in its expression or aberrant folding
in the sporadic forms can consequently result in impaired
neurotransmitter storage or release contributing to PD. In
case of a breakdown in vesicle handling, an increased
level of cytoplasmic DA may initiate damage by the
production of free radicals and the formation of toxic
intermediates with α-syn [4].
Recent research has focused on revealing the biochemical
and molecular interactions of α-syn and DA with implica-
tions on the rate of secretion of α-syn-DA oligomers to the
extracellular space, mitochondrial respiration and autophagy,
respectively [5, 6]. In vitro, oligomers are devoid of a
defined secondary structure, do not bind the amyloid specific
dye thioflavin T, exhibit various non-ordered aggregate
morphologies with alternate size and shape under electron
microscopy and are sodium-dodecyl-sulphate resistant [7].
Some early evidence has indicated that oxidated ligation of
DA stabilized α-syn yielding accumulation of DA- α-syn
protofibrils [8]. These α-syn-DA oligomeric forms had an
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altered ability for self-assembly and propensity to disrupt
biomembranes in a yeast model and may also be critical in
sustaining neurodegeneration in PD [9, 10]. Structurally, α-
syn is a natively disordered, 14,460 Da presynaptic protein
that contains some ordered regions and can take on a variety
of conformations depending on its immediate environment
and the presence of binding partners [11]. It is known to co-
populate both extended conformational states in equilib-
rium with more compact conformation states [12, 13].
Long range interactions between the C-terminal region
and central regions of the protein have been reported by
both nuclear magnetic resonance (NMR) and molecular
dynamics (MD) simulations and as such the protein
although unstructured has a conformation more compact
than would be expected of a random coil [14, 15].
Alterations in solution conditions such as pH, the
presence of metals or other binding ligands are known
to increase the population of the compact conformation,
correlating with increased aggregation rates as shown
both by spectroscopy [16–18] and in the gas phase by
IMS-MS [12, 13, 19]. Changes in solution conformation
were detected in the gas phase as changes in collisional
cross sectional area (Ω) consistent with a shift towards
globular like assemblies and an increased intensity of
lower charge state ions. The change in the charge state
distribution occurs due to a decrease in available surface
area able to take up H+ upon electrospray [20–22]. In a
study undertaken by Bernstein et al. [12] it was shown
that increasing injection energies (30, 50, 100 eV)
resulted in increasing arrival time distributions of the
compact conformation as the protein unfolded in the gas
phase because of increasing energy. A shift to the more
compact forms of α-syn as a result of acidification was
also demonstrated in this study with an increased
population of the compact state being observed [12].
Polyvalent metals (i.e., Cu2+, Fe3+, Co3+, and Mn2+)
enhance the ability of α-syn to aggregate and can lead to
increased rates of fibril formation in vitro [18, 23–25].
The resultant fibrils induced by the various cations have
a particular morphology and degree of toxicity [23, 26].
To better understand the residue specific effects of metal-
induced fibrillogenesis and structural transitions of
monomeric α-syn in response to copper binding, a
number of mapping studies have been undertaken
employing circular dichroism (CD), calorimetric titra-
tions, NMR, and electron paramagnetic resonance (EPR)
spectroscopy [27–29], demonstrating the population of a
compact species in the presence of this metal. This shift
to a more compact conformation on metal binding has also
been observed by ESI-MS, where again an increased popula-
tion of the compact state was observed on co-ordination of
copper [19]. These results indicate that changes in solution
condition leading to conformational change [12, 30–33] can be
subsequently observed in the gas phase [34] and suggest a role
for the collapsed partially folded state as the precursor to
amyloid formation akin to other amyloid systems [35, 36].
In order to investigate these conformational states in the
context of DA binding, we harnessed the potential of ESI-
IMS-MS as a platform to provide structural information in
the form of Ωs [37] and ligand binding through mass shifts.
The use of this technology in structural studies has been
documented [38, 39]. Here we demonstrated through
measurements of Ωs that the incremental uptake of the DA
pushes α-syn towards a highly extended state, becoming
fully populated upon the binding of three DA ligands. DA
bound uniquely to the most extended conformations of α-syn
indicating that the ligand binding site requires an extended
conformation. The population of this DA bound extended
state may represent the initial precursor state conformation
to the soluble DA induced oligomers over the more
amyloidogenic compact state. Tyr as a closely related
structural analog to DA displayed a much reduced binding
affinity to α-syn with a maximum of two ligands being
bound by the protein and as far as we are aware has also not
been reported to induce oligomerization of α-syn. Those Tyr
ligands that do bind appear to bind to the same extended
conformational state as the two DA ligands. Binding of the
third DA ligand may therefore be key in switching pathways
between amyloid-like aggregates and non-amyloid DA
induced higher order oligomers, however further experimen-
tal data would be required to confirm this theory.
Materials and Methods
Materials
Equine cytochrome c, horse heart myoglobin, bovine ubiquitin,
DA hydrochloride, glycine (Gly), α-Tyr, and ammonium
acetate were purchased from Sigma-Aldrich (Gillingham,
UK). Human, recombinant wild type α-syn was expressed in
E. coli BL21 (DE3) and purified as described previously [40].
The concentration of pure monomeric α-syn was determined
using the molar extinction constant 5960M−1 cm−1 at A280 on a
Jenway spectrophotometer.
Sample Preparations
Protein samples for ESI-IMS-MS experiments were prepared
by dissolving α-syn to a 40 μM final concentration and by
diluting DA or Tyr to a 6.25 mM final concentration in
aqueous solution of 50 mM ammonium acetate pH 6.8. The
following protein to ligand ratios of the working strength
solutions were analyzed: 1:125, 1:30, and 1:8 (α-syn:DA),
all prepared and mixed immediately prior to analysis. The
experiments were conducted either in the presence or
absence of 6-fold excess of Gly to avoid nonspecific
interactions.
ESI-IMS-MS Analysis
All spectra were acquired using a Synapt G2 HDMS
instrument (Waters, Manchester, UK) by use of gold coated
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home-made borosilicate nano-capillaries in positive mode.
Optimized instrumental settings for data acquisition were:
capillary voltage of 1.70–1.90 kV, cone voltage of 50 V,
source temperature of 60 °C, trap collision energy of 4.0 V,
transfer collision energy of 10 V, trap bias 45, backing
pressure of 3.1 mbar. IMS separations were performed at T-
wave velocities of Trap:311, IMS:800 and Transfer:200 m/s
and T-wave amplitudes of 4–15 V using 3.6 mbar pressure
of nitrogen gas maintained by a 90 mL/min gas flow.
Calibration curve for collisional cross sections was obtained
based on of multiple charge states of equine cytochrome c,
horse heart myoglobin and bovine ubiquitin (Sigma Aldrich)
as described previously [41]. For attaining denatured spectra,
all calibrants and mass standards were prepared before
injection at 10–15 μM and α-syn at 10 and 40 μM and
dissolved in 10 % formic acid, 50 % acetonitrile and 40 %
ultrapure water (vol/vol/vol), whilst instrumental settings
were maintained as mentioned before. Mass calibration was
carried out by an infusion of CsI cluster ions, and arrival
time distributions were determined by using the Mass Lynx
v4.1 software (Waters).
Results and Discussion
ESI-IMS-MS analysis was performed utilizing a Waters
Synapt G2 in positive ion mode. Typical tuning parameters
were initially varied extensively in order to investigate and
minimize any artifacts within the data. A range of capillary
(1.5 to 3.0 kV) and cone voltages (40–100 V) along with
changes in backing pressures between 1.0 and 7.0 mbar and
trap, transfer (4–20), bias (45–100) and voltages along with
wave guide parameters were optimized. Final experimental
parameters are listed in the Section 2. Supplementary
Figure 1 shows Ωs of known globular proteins with similar
Figure 1. Driftscope plots obtained from 50 mM aqueous ammonium acetate solution of 40 μM α-syn, at pH 6.8 with or
without further addition of either DA or Tyr at 6.25 mM. The x axis represents drift time (ms), on the y axis m/z is shown; square
root display. Corresponding mass spectrum for each acquisition is overlaid on the right of each Driftscope plot indicating
charge states and the presence or absence of the appropriate ligands (a) wild-type α-syn, (b) α-syn in the presence of
DA, (c) α-syn in the presence of Tyr, (d) α-syn in the presence of DA and Gly
1348 E. Illes-Toth et al.: Dopamine Binding to α-Synuclein
mass to α-syn acquired under our experimental conditions.
The Ωs of these known proteins are very close to those
previously reported [41] and well within theoretically
calculated [42, 43] values. Our ESI-IMS-MS analysis of
wild-type α-syn revealed a primarily extended population
(charge state ions +18 to +8) and a subpopulation of a more
compact conformational series (charge state ions +8 to +6)
with multiple overlapping features in both series and a less
observable dimeric species under native conditions
(Figure 1a). Figure 2 outlines the resolvable Ω of the
individual charge state ions observed under native condi-
tions. Within the extended series three charge state ions +11,
+12, and +13 show at least two major resolvable conforma-
tions. Since these charge state represented the most intense
peaks within the spectra it is possible that the other charge
state ions also have multiple features but we were unable to
detect them due to either low intensity or resolution.
Alternatively, the larger Ω of the states could be an artefact
induced by Coulombic repulsion due to the high charge on
the molecule. Another alternative explanation is that there
are two major distinguishable conformational families
present within the extended conformations, the first
encompassing charge state ions +13 to +8 and the second
encompassing charge state ions +18 to +11, these two major
states would therefore have the +13 to +11 charge states in
common. This theory is consistent with the charge state
distribution analysis of Frimpong et al. [13] detailed below.
It is known that compact states in solution when
subjected to ESI acquire fewer charges and have a narrow
charge state distribution, whereas unfolded states acquire a
large number of charges and have a wide charge state
distribution [20, 21]. The standard MS data presented in
Figure 1a and Supplementary Figure 2 clearly showed multiple
charge state distributions centered at the +13 and +7 charge
state ions. Both the +7 and +8 charge state ions were more
intense than would be expected for a completely unfolded
protein. This charge state distribution is consistent with known
data for globular proteins and, given the mass of the protein
(14.6 kDa), we would predict a narrow distribution centered on
the +7 charge state ion [20–22] as observed here. In order to
further confirm that the compact conformation reflected that
present in solution and did not arise solely because of transfer
to the gas phase, an α-syn mass spectrum was acquired under
fully denaturing conditions (50 % acetonitrile, 40 % H2O, and
10 % formic acid) Supplementary Figure 3. If the lower charge
state ions of the protein underwent collapse during acquisition,
it would be expected that this is observed regardless of the
Figure 2. Conformational series of α-syn. Filled, black
circles: extended conformational features, black triangles:
compact conformational forms. The dotted lines represent
theoretical Ωs calculated for structures having an all α-helical
or globular conformation along with the Ω for the extended
conformation as reported by Bernstein et al. [12]. Neither of
these calculated or estimated values are true representations
of the protein’s molecular organization; they have been
adopted and superimposed on our experimental data to aid
comparison. Experimentally measured values represent three
independent measurements taken on alternate days using
independent protein preparations
Figure 3. Binding of DA and binding of Tyr to α-syn at the
+13 charge state ion. Spectra were acquired at protein to DA
ratios of (a) 1:125, (b) 1:30, and (c) 1:8. Incrementally bound
α-syn DA adducts (1–3) are marked with black circles, the m/z
1113.3 is the apo form of α-syn [M + 13H]+13. Stars illustrate
the Tyr-α-syn adducts. X axis represents the m/z values and
the y axis represents relative abundance in % of the base
peak
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solution conditions from which the protein was acquired.
Charge state ions between +19 and +8 were observed for fully
denatured α-syn with no evidence of a significant compact
conformation at the lower charge state ions akin to that seen
under native conditions. In addition, the intensity of the charge
state ions +9 to +8 were markedly lower than that observed
under native conditions, indicating a single extended confor-
mation. In comparison with other published data, Frimpong et
al. ascertained four states of the protein in the pH range of 4–8:
an extended form (U) at high charge states (+21 to +13 charge
state ions), I1 representing helix-rich intermediates (+16
to +10 charge state ions), I2 entailing β-rich intermediate
state (+13 to +7 charge state ions), and a highly compact
forms spanning low charge states (+9 to +6 charge state ions)
[13]. In negative ion mode, a study by the Bowers group
reported two main conformational families for wild type
A53T and A30P α-syn, one dominating the lower charge
states (−16 to −6 charge state ions) centered at −11 with
multiple features and one prevalent at high charge states (−8
to −6 charge state ions) [34]. The compact state of α-syn was
modeled by a globular structure ~1500 Å2, whereas the
extended state had a reported Ω of 2530 Å2 [12] with a
spread between ~1800 Å2 and 3000 Å2 over all charge states
[34]. The extended state was shown to be more compact than
a fully random coil conformation as predicted by small angle
X-ray scattering (SAXS) and NMR [16]. These model and
reported Ω values have been taken from these publications
[12, 43] and plotted onto Figure 2 in order to compare the
experimental data acquired here against both model and
previously reported values. Ωs of each of the charge states
and conformational families observed here are in agreement
with these previously reported values [12, 34] and the Ω of
the compact state of α-syn observed is comparable both
theoretically (Figure 2) and experimentally (Supplementary
Figure 1 and Table 1) to globular proteins of a similar mass
[13, 34, 41, 42, 44].
Numerous in vitro studies have shown that DA and some
of its metabolites act as modulators of α-syn oligomerization
and inhibit its fibrillization [7, 8, 45, 46]. ESI-MS in
conjunction with other biophysical methods has demonstrat-
ed that one intact, unoxidized α-syn is capable of binding 3
DA molecules that in turn led to oligomerization of a range
of higher order protofibril species [47]. Here, the effect of
DA binding on the population of conformational states was
Figure 4. Ωs of incremental adducts of (a) DA and (b) Tyr bound to α-syn at the +13 and +7 charge state ions compared, in
addition α-syn only acquired in the absence of ligand is shown The +13 and +7 charge state ions are highlighted as being
representative of the extended and compact states, respectively. Alternate populations are indicated by vertical dotted lines
with corresponding Ω areas. Black line: α-syn only, navy blue: apo-form of the protein remaining ligand-free in the presence of
DA, purple: 1 DA bound, grey: 2 DA bound and light blue: 3 DA bound. No ligand binding was observed at the +7 charge state
ion as highlighted with both a black line (α-syn only) and a navy blue line (remained ligand free in the presence of DA). (b) Tyr
adducts of +13 and +7 charge state ions or unbound populations at the 1:125 ratio are shown. The black line indicates α-syn
only, navy line shows the protein remained ligand-free, 1 Try bound protein is indicated by a purple line, the 2 Tyr bound form is
denoted by a grey line. The +7 charge state ion remained ligand-free (navy blue line) at the 1:125 molar ratio overlapping the Ω
of α-syn only (black line)
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examined in conjunction with changes in the Ωs. α-Syn-DA
complexes observed by ESI-IMS-MS are shown in Figure 1
and the ESI-MS spectra of apo α-syn, α-syn-DA, α-syn-Tyr,
and α-syn-DA-Gly is included as Supplementary Figure 2.
DA ligands are highlighted with black dots on the mass
spectrum in Figure 1b and are only observed on the +17 to
+10 charge states. If the extended state was the sole
conformation present or DA binding was nonspecific, then
it might be expected that DA adducts would be present on
all charge state ions (+6 to +17) in the gas phase. However,
binding of 3 DA could be only observed to the +11 to +17
charge state ions in the same envelope that contains the most
extended forms of the protein. The +10 charge state ion
bound only a single DA ligand. The lower charge state ions
+6 to +9 did not show any DA binding and these ions in the
absence of DA still retained the structural features of the
most compact conformation. It is possible that ligand
binding stabilizes the extended state preventing structural
collapse; however, the conformational states that the ligand
binds appear to be present in the absence of the ligand. This
data can, therefore, be interpreted as DA bound only to the
most extended conformations in solution.
Tyr serves as an early precursor in the synthesis of DA
[48] and differs only by a hydroxyl group and a carboxyl
group in its chemical composition. Figure 1c details the
resultant α-syn-Tyr spectra obtained from a 1:125 ratio of α-
syn:Tyr. Tyr adducts are marked with single or double stars
according to the number of ligands bound. A maximum of
two molecules of Tyr were involved in complex formation
with α-syn indicated by one or two stars above the respective
peaks; these ions, however, had a markedly lower intensity
compared with apo- and DA-bound forms of α-syn
(Figure 3). Again, ligand binding was only observed to the
+17 to +11 charge state ions as for DA, and no binding was
observed to the more compact conformational populations of
α-syn. Inclusion of Gly is useful when preventing
nonspecific or low affinity binding and here it completely
negated the ability of DA to bind to α-syn as shown on
Figure 1d, suggesting the interactions were low affinity and
electrostatic in nature. Together, these results demonstrated
that the extended conformations populating the +17 to +11
charge state ions of α-syn will readily bind up to 1–3 DA
molecules, have a lower affinity for Tyr, and that this
binding could be overcome by the presence of Gly.
To further elucidate the conformational transitions taking
place upon DA coordination, we concentrated on selected
populations of the extended and compact conformational
families of α-syn (Figure 4). We assigned the +13 charge
state ion as being representative of the extended conforma-
tional family. The arrival time distribution for the +13
charge state ion acquired in the absence of any DA is shown
in Figure 3a: black line and indicates two clearly resolvable
peaks at ~2590 Å2 and ~2720 Å2 along with another less
pronounced feature at ~2500 Å2. In the presence of DA, the
most extended forms of the protein bound to the ligand with
a shift toward the more extended states. The stepwise
binding of 1, 2, or 3 DA ligands initiated a shift in the
conformation towards the more extended conformations
(Figure 4a) as evidenced by an increasing drift time and
increase in the Ωs. Upon binding of 3 DA ligands, the
~2500 Å2 and ~2590 Å2 states were absent and the highly
extended state, ~2720 Å2 was uniquely observed. The
remaining apo-form of the protein acquired in the presence
of DA predominantly showed the populations of the
~2500 Å2 conformations and significant depletion of the
~2590 Å2 and ~2720 Å2 conformations, presumably as these
conformations were now ligand bound. The +7 charge state
ion was taken as being representative of the compact states
of α-syn and co-populated compact conformations along
with a minor population of the extended state. DA binding
was not observed to any of the compact conformations, nor a
shift in Ω was observed. One or two Tyr ligands were also
observed to bind to the extended states of α-syn charge states
+17 to +11. Akin to DA, the binding was to the most extended
Figure 5. Ωs of α-syn co-ordinating DA or remaining ligand
free at +13 charge state. Ωs are shown at three different
protein to ligand molar ratios; 1:8 is marked with a black line,
1:30 is marked with a grey line and 1:125 is illustrated with a
dashed line. The protein remained ligand-free in the presence
of the ligand (0 DA) is depicted at the top then incremental
adducts of α-syn-DA are placed sequentially below as
follows: 1 DA-, 2 DA- and 3 DA-bound to α-syn at three
alternate protein to DA molar ratios. Data was normalized to
the most intense peak of the spectra
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forms of the protein. However, as Figure 3 demonstrates, this
binding was much weaker compared with DA at the same
protein to ligand ratios. Therefore, Tyr was able to bind to
α-syn in a similar manner to DA but had a much reduced
affinity. These results, therefore, demonstrated that DA binds
to α-syn in a conformational dependent manner, binding
exclusively to the most extended states of the protein.
To assess that adduct formation and subsequent confor-
mational rearrangement following DA ligation occurs
through repeated measurements and at reduced dilutions
yet still higher than physiological DA levels [49], we
conducted replicate experiments at 1:125, 1:30, and 1:8
ratios (α-syn:DA). Up to 3 DA molecules were coordinated
in each case, however, the intensity of the adduct peaks
became lower as the ligand concentration decreased
(Figures 3 and 5). Ratios of 1:125 and 1:30 were required
to observe binding of 3 DA ligands to α-syn. The majority of
the protein was present in the most extended states
(~2720 Å2) upon binding of 3 DA molecules and at high
ratios of α-syn:DA the ~2500 Å2 state was effectively
absent. Replicate experiments have shown excellent agree-
ment in calculated Ωs of the three independent measure-
ments taken from different protein preparations. The
alternate α-syn:DA ratios did not dramatically affect the
absolute Ωs recorded of the extended state conformations,
with 2 and 3 DA bound at low ratios inducing the same Ω as
2 and 3 DA bound at high ratios. These results would
indicate that it is the specific binding of the ligand that
causes the conformational change rather than a change in the
solution environment due to the presence of the DA.
Conclusions
Crucial insights have been gained into how DA might be
involved in aggregation and the fibrillization of α-syn from
in vitro studies [7–9, 46] and evidence now emerges that
polymers of α-syn-DA or other reactive intermediates are
linked to neuronal cell death in PD [6]. Although the co-
ordination of DA to α-syn has been observed before [47],
here we have shown that coordination of three DA
molecules to wild-type α-syn induces a highly extended
conformation specifically binding to the extended states and
causes an increase in Ω. No binding of DA was observed
under our conditions to the compact states. This concept of
expansion is not dissimilar from that which Rekas et al. have
reported. In their study, α-syn was incubated for 5 to 7 d in
the presence of DA, after which the protein was observed to
be oxidized. The resulting Met-oxidized α-syn monomer and
α-syn-DA trimer had elongated shapes versus untreated
monomers based on SAXS CD results, which could be
brought about by the association of the DA bound
extended states observed here prior to incubation. How-
ever, there are marked differences between the experi-
mental conditions used in the study of Rekas et al. and
our own buffer conditions and protein concentration [50].
Met-oxidation has been observed to be required for DA
induced oligomerization [51, 52]. Utilizing short time
frames (G5 min) we did not observe extensive Met-
oxidation of α-syn. Oxidation was only seen at the highest
charge states and were predominantly lower intensity
adducts beside the more pronounced, unoxidized higher
intensity DA-bound peaks and ligand-free peaks. Howev-
er, minor oxidation was present without any prior addition
of ligand and, hence, did not result from DA exposure.
Longer incubations (912 h) of α-syn in the presence of
DA did result in oxidation of the monomeric protein
(Supplementary Figure 4) akin to other studies [53].
Regardless of this observation, during the time frame of
our experiments, the unoxidized α-syn-DA complex was
considerably more dominant, demonstrating oxidation is
not required for initial binding and further oxidation is a
result of long-term exposure to DA.
Alternate ligands have been reported to bind to α-syn by a
range of mass spectrometry methods each affecting the
conformational state of the monomer in its own way.
Electrospray ionization-electron capture dissociation-mass
spectrometry/mass spectrometry (ESI-ECD-MS/MS) has
been used in probing non-covalent protein-ligand binding
interactions in relation to α-syn. Spermine is a polyamine
compound widely found in many tissues and has a role in
increasing the aggregation rate of α-syn [30]. The spermine
binding site has been localized to the C-terminal 106–138
amino acids residues of the wild-type α-syn, as demonstrated
by Xie et al. [54] using ESI-ECD-MS/MS, consistently with
previous NMR data [31]. Changes in the charge state
distribution were, however, not observed in this study. The
DA binding site of α-syn is also located on the highly
negatively charged C-terminal region of the protein, at
125YEMPS129; this sequence has been implicated in DA
interactions and in modulation of DA induced aggregation
[45]. This region, however, has been reported to be
necessary only for oxidation but not complete binding [52].
Interestingly and similarly to the DA binding results here,
data presented in the Supplementary Information of the
paper by Xie et al. showed the 1:2 protein–ligand complex
binding only to the high charge state ions (+18 to +11
charge state ions) [54]. ESI-IMS-MS has also been used to
gain conformational information for the familial point
mutation of α-syn A53T upon spermine binding. Evidence
from NMR data suggests that although spermine binds
specifically to the C-terminal of α-syn, it induces changes
in the N-terminal in the proximity of Gly and Tyr residues
in the region of amino acids 22–93 and leads to the
adoption of a β-sheet conformation typical of fibrillar α-syn
[31]. Spectra acquired in negative ion mode by Grabenauer
et al. [34] reported a significantly greater percentage of the
population in the compact form in the spermine:protein
complex as compared to the unbound protein. Either the
presence of this point mutation is involved in the binding
of spermine through long-range interactions or its inclusion
facilitates aggregation through preferential population of
the compact state.
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Here, the shift in the population towards a more extended
state on DA binding may well be the point at which the
aggregation pathway is switched from the amyloid-forming
pathway linked to the collapsed state [16, 19, 55] to the
pathway resulting in soluble DA induced oligomers. Both
DA and Tyr bind uniquely to the extended conformational
state of α-syn, yet Tyr is not known to induce aggregation.
The binding of the third DA ligand to the most extended
state may well be the critical step in switching the
aggregation pathways as only two Tyr ligands are observed
to bind α-syn. However, further mutational experiments that
limit the DA binding will be required to confirm this theory.
From the data presented here we can conclude that DA first
binds to extended conformations of the protein, followed by
oxidation of Met residues [51, 52] resulting in oligomer
formation. Previous SAXS data has demonstrated that DA
induced α-syn oligomers on extended incubation had a
highly extended conformation [50], and this structure may
well result from the stabilization of a highly extended
monomeric state.
We therefore propose that DA is a potent modulator of α-
syn assembly and exerts its effect at the very early stages of
aggregation by influencing the conformational dynamics of
the monomeric protein.
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